07-Mar-17 In 2016, the most people from CIS countries looking for treatment abroad were from Russia, Ukraine and Kazakhstan. The Russian Federation and Belarus hold 57% of the total CIS market, with similar preferred destinations. Both countries preferred Germany and Israel for treatment in 2016. Most patients going abroad went for oncology, orthopaedic, neurosurgery and ophthalmology treatment. [image: IMTJ]

21-Feb-17 India is emerging as a hotspot for medical tourism with arrivals of foreign tourists on medical visas showing phenomenal growth in the last two years. 2013 to 2015 witnessed growth of 140 percent, to 134,000 visits in 2015. The majority of patients are from the Middle East, Africa, Bangladesh, Afghanistan, Maldives, Pakistan, Bhutan and Sri Lanka. [image: Business Standard]

14-Feb-17 The medical tourism industry in Malaysia is expected to achieve revenue of MYR1.3 bn (USD290 mn) in 2017, said the Malaysia Healthcare Travel Council. MHTC's CEO Sherene Azli said the industry is experiencing a growth of 30 per cent year-on-year. "Malaysia has the ecosystem and infrastructure to provide quality end-to-end healthcare system and services that are globally competitive," she said. [image: Reuters]

08-Feb-17 Smith & Nephew reported a 7 percent drop in profit, as tough conditions in China and Saudi Arabia kept growth in check. The company has focused on emerging markets in recent years to boost sluggish demand in the US and Europe, where it competes with Zimmer and Stryker. The company delivered growth, but not at the level it had wanted. [image: Smith & Nephew]

01-Feb-17 The Middle East region, which includes some countries that are a target of Trump's ban, is the top source of patients who travel to the US for medical care. The travel ban could prompt international patients to skip the US and take their dollars elsewhere, such as to Germany or Thailand. [image: Wikimedia Commons]